s effort and make sure their achievement. 3)Measure the outcome scales.

2 trials

Sponsors

University of Hyogo

Conditions

hematological malignancies oral mucositis associated with cancer therapyskin toxicity associated with molecularly targeted drug

Unknown Phase

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapy

Active, not recruitingJPRN-UMIN000016948

University of Hyogohematological malignancies oral mucositis associated with cancer therapy

Start: 2015-06-01Target: 20Updated: 2026-06-29

Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug

Active, not recruitingJPRN-UMIN000016947

University of Hyogoskin toxicity associated with molecularly targeted drug

Start: 2015-06-01Target: 20Updated: 2026-06-29